Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (61-70 of 436) with videos related to

Pageof 44
Sort By:
Journal of Thrombosis and Thrombolysis|January 27, 2021
COVID-19 and its sequelae: a platform for optimal patient care, discovery and trainingRichard C Becker
Journal of Thrombosis and Thrombolysis|October 24, 2003
Factor Xa-A pleuripotential proteaseRichard C Becker
Journal of Thrombosis and Thrombolysis|September 1, 2005
Cell-based models of coagulation: a paradigm in evolutionRichard C Becker
Texas Heart Institute Journal|January 6, 2006
COX-2 inhibitorsRichard C Becker
Current Cardiology Reports|June 8, 2002
Choice of agents to limit the coagulation cascade in acute coronary syndromesRichard C Becker
Journal of the American College of Cardiology|October 30, 2007
Emerging paradigms, platforms, and unifying themes in biomarker scienceRichard C Becker
Journal of Thrombosis and Thrombolysis|April 24, 2007
Emergence of factor IXa as a target for pharmacologic inhibition: editors pageRichard C Becker
Clinical Cardiology|March 31, 2004
Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapyRichard C Becker
Journal of Thrombosis and Thrombolysis|March 25, 2005
Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapyRichard C Becker
Journal of Thrombosis and Thrombolysis|August 6, 2005
Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigmRichard C Becker
Pageof 44

Showing results (61-70 of 436) with videos related to

Sort By:
Pageof 44
Journal of Thrombosis and Thrombolysis|January 27, 2021
COVID-19 and its sequelae: a platform for optimal patient care, discovery and trainingRichard C Becker
Journal of Thrombosis and Thrombolysis|October 24, 2003
Factor Xa-A pleuripotential proteaseRichard C Becker
Journal of Thrombosis and Thrombolysis|September 1, 2005
Cell-based models of coagulation: a paradigm in evolutionRichard C Becker
Texas Heart Institute Journal|January 6, 2006
COX-2 inhibitorsRichard C Becker
Current Cardiology Reports|June 8, 2002
Choice of agents to limit the coagulation cascade in acute coronary syndromesRichard C Becker
Journal of the American College of Cardiology|October 30, 2007
Emerging paradigms, platforms, and unifying themes in biomarker scienceRichard C Becker
Journal of Thrombosis and Thrombolysis|April 24, 2007
Emergence of factor IXa as a target for pharmacologic inhibition: editors pageRichard C Becker
Clinical Cardiology|March 31, 2004
Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapyRichard C Becker
Journal of Thrombosis and Thrombolysis|March 25, 2005
Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapyRichard C Becker
Journal of Thrombosis and Thrombolysis|August 6, 2005
Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigmRichard C Becker
Pageof 44